ReviewPlant foods for human nutrition (Dordrecht, Netherlands)2025
Unraveling the Therapeutic Benefits of Amaranthus Species: a Comprehensive Review.
Review in Plant foods for human nutrition (Dordrecht, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of VAYPQCV, a Gastrointestinally Stable Competitive DPP-IV Inhibitory Peptide from Bitter Leaf (Vernonia amygdalina).Plant foods for human nutrition (Dordrecht, Netherlands) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amaranthus species are often underutilized plants that are rich in phenolic acids, flavonoids, betalains, saponins, and unsaturated fatty acids, which offer various health benefits. This review explores their nutritional and pharmacological properties, including antioxidant, anticancer, antidiabetic, heart-protective, antimicrobial, liver-protective, and antimalarial effects. Studies show that the bioactive compounds in Amaranthus help reduce oxidative stress, promote cell death in damaged cells, regulate fat metabolism, and reduce inflammation, making them useful for managing chronic diseases. Effectiveness varies depending on the Amaranthus species, plant part, extraction method, and dose. However, limitations like low bioavailability and a lack of clinical studies remain. New approaches such as nano-encapsulation, lipid co‑formulation, and food matrix fortification show promise in improving their absorption and stability of different compounds. This review underscores the therapeutic potential of Amaranthus spp. while calling for careful dosing and human trials. Future research can help develop functional foods, supplements, and cosmetics that harness these benefits, turning traditional knowledge into proven health solutions.
Indexed as
Identifiers
41137874What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.